Key result
Targeting a blood pressure goal of 135/85 mm Hg is proposed as a reasonable compromise for diabetic patients, as lowering systolic pressure to <130 mm Hg reduces stroke but not coronary events.
Why the study?
Does intensive blood pressure lowering reduce cardiovascular events in patients with diabetes?
Does intensive blood pressure lowering reduce cardiovascular events in patients with diabetes?
A blood pressure goal of 135/85 mm Hg is proposed as a reasonable compromise for diabetic patients, balancing stroke reduction with the lack of coronary event benefit at lower targets.
Answers are grounded in this paper and cite their sources.
May support 135/85 mm Hg target in diabetes; leaves open optimal threshold pending dedicated trials.
Both impaired glucose tolerance and diabetes are associated with substantially increased prevalence of hypertension, cardiovascular and renal disease. The goal for hypertension treatment in diabetic patients is in evolution, because of recent clinical trials. For example, the results of the recent Action to Control Cardiovascular Risk in Diabetes-BP Arm (ACCORD BP) trial failed to show an additional benefit on cardiovascular event reduction at a mean systolic BP of 119 mm Hg. A post hoc analysis of 6,400 patients with type 2 diabetes from the International Verapamil-Trandolapril Study (INVEST) also failed to show additional cardiovascular risk reduction among patients who achieved a BP <130/80 mm Hg. While the evidence fails to support a lower BP goal to reduce coronary events, there was a risk reduction in stroke events both in ACCORD and the Appropriate Blood Pressure Control in NIDDM (ABCD) trial. A number of other clinical trials also demonstrate that when systolic pressures fall to less than 130 mm Hg, a reduction in stroke but not coronary disease events occurs. Thus, the precise BP goal for diabetic patients remains unresolved. We would posit that a BP goal of 135/85 mm Hg may be a reasonable compromise when viewing the impact of BP reduction on composite stroke and coronary artery disease in extant trials.
No takes yet. Share an insight, caveat, or question.
Garcia‐Touza et al. (2011) conducted a review in Hypertension in patients with diabetes. Intensive blood pressure control vs. Standard blood pressure control was evaluated on Cardiovascular events, stroke, and coronary disease events. Targeting a blood pressure goal of 135/85 mm Hg is proposed as a reasonable compromise for diabetic patients, as lowering systolic pressure to <130 mm Hg reduces stroke but not coronary events.
Synapse has enriched 10 related papers. Consider them for comparative context: